Bermoprofen

Research use only, not for human use.

Bermoprofen (AD-1590) is an orally active non-steroidal anti-inflammatory compound with analgesic properties, utilized in gastric ulcer studies.

Bermoprofen (AD-1590) is an orally active non-steroidal anti-inflammatory agent. Bermoprofen has potent antipyretic activities with a short biological half-life. Bermoprofen is a potent antagonist of LPS-induced fever in rabbits.

Bermoprofen (AD-1590) shows ulcerogenic activity as a side-effect like other nonsteroidal anti-inflammatory agents.

Bermoprofen (AD-1590) (0.04-0.1 mg/kg; p.o.) shows a dose-related antipyretic activity in LPS-induced febrile rabbits.Animal Model:Male albino rabbits, 2.3-3 kg Dosage:0.04, 0.4, 0.1 mg/kg Administration:Oral; given 1 h after i.v. injection of LPS Result:Inhibited significantly the rise in rectal temperature at doses of 0.1 mg/kg or more, the temperature returned approximately to normal after 0.4 mg/kg.

——

Others

Other Targets

Others

——

——

78499-27-1

296.32

C18H16O4

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (337.47 mM; Ultrasonic )

O=C(O)C(C1=CC=C2OC3=CC=C(C=C3CC(=O)C2=C1)C)C

——

(-20℃)

With Ice Pack

≥ 2 years